A Saudi Heart Association Position Statement on the use of DOACs in Patients With Arterial and Venous Thrombosis. [PDF]
Alhabeeb W+9 more
europepmc +1 more source
Hemostasis and Gingival Healing-Polyurethane Adhesive Postextraction Under Rivaroxaban Therapy in a Rodent Model. [PDF]
Heitzer M+7 more
europepmc +1 more source
Factors influencing medication adherence for deep vein thrombosis prevention in post-discharge patients after joint replacement surgery: a qualitative study based on Protection Motivation Theory. [PDF]
Fu F+8 more
europepmc +1 more source
Successful rivaroxaban and doxycycline therapy for Mycoplasma pneumonia with pulmonary embolism in children: a case report. [PDF]
Xiaoqian F, Hemin L.
europepmc +1 more source
Higher dose of rivaroxaban for the treatment of venous thromboembolism in a 15-year-old Asian child with antithrombin deficiency: A case report and literature review. [PDF]
Liang CS, Chen YX, Liu F, Yue YD, Du LP.
europepmc +1 more source
Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update. [PDF]
Franco-Moreno A+4 more
europepmc +1 more source
Rivaroxaban versus Enoxaparin in Patients with Radial Artery Occlusion after Transradial Coronary Catheterization: A Pilot Randomization Trial. [PDF]
Maadani M+11 more
europepmc +1 more source
Beyond Routine Monitoring: A Comprehensive Review of Direct Oral Anticoagulants and the Role of Coagulation Profiles in Their Management. [PDF]
Jayakumar J+9 more
europepmc +1 more source
Correlation of rivaroxaban solubility in mixed solvents for optimization of solubility using machine learning analysis and validation. [PDF]
Alanazi M+3 more
europepmc +1 more source